NEW YORK (GenomeWeb) – Roka Bioscience reported on Friday that its second quarter revenues rose 20 percent year over year thanks to an increase in the number of Atlas molecular pathogen detection instruments placed with customers.

For the three months ended June 30, the firm reported total revenues of $1.8 million, up from $1.5 million a year ago. As of June 30, the company had placed 46 instruments with customers under commercial agreements, up from 44 instruments as of March 31.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.